Medventions and Mitacs Collaboration: A New Paradigm for Cultivating Medical Technology Entrepreneurship Talent in Canada

Event: From Case-by-Case Collaboration to Systemic Talent Pipeline

On June 9, 2026, at the Medventions Toronto Innovation Day, Dr. Ahmed Nasef, co-founder and co-director of Medventions, announced a comprehensive cooperation agreement with Mitacs (the Medventions Mitacs Umbrella Agreement). This agreement will support Medventions fellowship programs in Ontario, Nova Scotia, and Newfoundland and Labrador over the next two years, totaling 39 internship positions. As early as 2021, Sunnybrook Research Institute and Mitacs had already collaborated; this agreement formalizes and accelerates the process, enabling more health technology talents to be trained nationwide.

Reason: Bridging the Gap Between Research and Clinical Practice

Founded at Sunnybrook Research Institute, Medventions is a health technology innovation fellowship program focused on clinical needs. Its unique value lies in immersing fellows in real clinical environments, observing medical processes, and interacting with clinicians, thereby accurately identifying the genuine needs of the Canadian healthcare system and developing solutions. Dr. Stephen Lucas, President and CEO of Mitacs, noted: "The most transformative breakthroughs in healthcare often occur at the intersection of rigorous research and real clinical insights." This collaboration aims to remove barriers between researchers, clinicians, and industry, creating a direct path from innovation to patient impact.

Impact on Canadian Industry: Strengthening the Health Technology Talent Supply Chain

Canada's health technology industry has long faced a talent shortage, especially for composite talents with both clinical insight and entrepreneurial ability. The Medventions program directly addresses this gap through systematic clinical immersion training. As a bridge connecting academia and industry, Mitacs' funding support (co-funded by the federal and multiple provincial governments) lowers the barrier for companies to participate in talent development. Although the 39 internship positions are limited in scale, they serve as a replicable model that is expected to promote the establishment of more similar projects nationwide, forming a large-scale pipeline for health technology entrepreneurial talent.

Significance for Global Tech Competition: Model Innovation in Health Technology Entrepreneurship Education

Traditional health technology entrepreneurship education mostly relies on classroom theory or laboratory research, lacking real clinical scenario training. The Medventions model—embedding fellows in hospitals to directly observe clinical pain points—represents a shift from "technology push" to "demand pull." This model is highly aligned with the global health technology trend of "clinically need-driven" R&D. If Canada can take the lead in establishing a mature clinical immersion entrepreneurship training system, it will occupy a unique advantage in the global competition for health technology talent.

Potential Changes in the Next 3-10 YearsIn the short term, this collaboration will accelerate the transformation of existing innovations, with projects from the INOVAIT Network (Image-Guided Therapy and AI Network) and Sunnybrook Research Institute directly benefiting. In the medium term, such partnerships may push Canadian provinces to further coordinate medical technology innovation policies, fostering cross-regional talent mobility and resource-sharing mechanisms. In the long term, if clinical immersive training becomes the standard configuration for medical technology entrepreneurship education in Canada, it will attract international talent and capital, positioning Canada as a key node for global medical technology entrepreneurship incubation.

Truly Noteworthy Long-Term Trends

The collaboration between Medventions and Mitacs is not an isolated funding event; it reveals a key trend: medical technology innovation is shifting from "point breakthroughs" to "systematic talent infrastructure building." With its public healthcare system, network of research hospitals, and tripartite collaboration mechanism among government, academia, and industry, Canada possesses unique conditions to build a world-leading "clinically driven" medical technology entrepreneurship ecosystem. The success or failure of this collaboration model will determine whether Canada can transform from a "follower" to a "standard setter" in the global medical technology race. For Canada's technology industry, investing in talent programs that bridge the "last mile" holds far greater strategic significance than short-term technological innovation—it concerns the resilience of the entire innovation ecosystem.